Stanozolol 10 - Livewell Pharmaceuticals

Stanozolol's entrance into U.S. medicine began in 1962 under the trade name Winstrol. Produced by Winthrop Laboratories, it gained early recognition for treating catabolic states and growth disorders. Unlike many anabolic agents, it offered oral bioavailability and lacked aromatization, minimizing estrogenic risks. Its unique DHT-derived structure was suited to preserving muscle tissue in patients suffering from chronic illness or trauma. Eventually removed from U.S. production, it continues to be used abroad, most notably in veterinary contexts, where injectable formats are still available.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Stanozolol 10 by Livewell Pharmaceuticals, consult with your doctor or healthcare professional.